Paulson & Co’s Insulet PODD Stock Holding History

Paulson & Co’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-25,000	Closed	-$1.28M	–	80
2017 Q2	$1.28M	Buy	+25,000	New	+$1.09M	0.02%	98

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Paulson & Co's PODD Position: Q3 2017 in Review

Paulson & Co sold out of Insulet (PODD) in Q3 2017, closing a stake of 25,000 shares — an estimated $1.28M sold.

Paulson & Co first reported a position in PODD in Q2 2017 and held it in 1 quarter. The position peaked at $1.28M in Q2 2017. 174 funds tracked by Wall St. Rank hold PODD as of Q3 2017.

Paulson & Co reported no remaining Insulet position as of Q3 2017 after selling out during the quarter.
Paulson & Co sold 25,000 Insulet shares in Q3 2017, an estimated $1.28M.
Paulson & Co first reported a position in Insulet in Q2 2017 and held it in 1 quarter.
Paulson & Co's Insulet position peaked at $1.28M in Q2 2017.
174 funds tracked by Wall St. Rank held Insulet as of Q3 2017.

Based on Paulson & Co's 13F filing for Q3 2017, filed 14 Nov 2017.